FDA rapidly approves HIV protease inhibitors for children.
Fox
J L
JL
D000328:Adult; D019380:Anti-HIV Agents / Q000592:standards / Q000627:therapeutic use*; D002648:Child; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000592:standards / Q000627:therapeutic use*; D006801:Humans; D007546:Isoquinolines / Q000592:standards / Q000627:therapeutic use*; D019888:Nelfinavir; D019438:Ritonavir / Q000592:standards / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000592:standards / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D013451:Sulfonic Acids; D019888:Nelfinavir; D019438:Ritonavir